ReviewLeukemia2021
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia.
Aline Renneville et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled ittrialcites it